帕金森病患者的基于表现的测试:结果得分和可靠性
Carolina Luisa de Almeida Soares1, Isabel Lopes Ribeiro1, Poliana do Amaral Yamaguchi Benfica1
1Department of Physical Therapy, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Clinical rehabilitation
|November 11, 2025
概括
对于患有帕金森病的人来说,像Timed Up and Go这样的移动性测试的一次重复足以进行可靠的评估. 这简化了移动性测试,为帕金森病患者提供一致的结果.
科学领域:
- 神经学 神经学
- 康复科学 康复科学 康复科学
- 运动障碍 运动障碍
背景情况:
- 帕金森病 (PD) 显著影响移动性,需要可靠的评估工具.
- 基于绩效的测试对于评估PD患者的功能移动性至关重要.
- 在PD中,这些测试的最佳重复次数尚不清楚.
研究的目的:
- 为了比较帕金森病患者关键移动性测试的结果得分和可靠性.
- 确定是否需要一次,两次或三次重复来进行可靠的测量.
- 在不同的重复协议中评估互评测和测试重试的可靠性.
主要方法:
- 一项涉及52名帕金森病患者的可靠性研究.
- 他们进行了四项基于表现的测试:定时起床和起床,10米步行测试 (舒适和最大速度) 和五次坐立测试.
- 两个独立评级人员在两次会议 (7-14天间隔) 中重复评估,使用ANOVA和ICC进行分析.
主要成果:
- 所有测试的结果分数在一次,两次和三次重复中都相似.
- 对于大多数测试,观察到高至非常高的测试复试可靠性 (ICC 0.730.96) 和评审者间可靠性 (ICC 0.840.96).
- 五次坐立测试显示了单次重复的中等级别可靠性 (ICC=0.68).
结论:
- 在熟悉之后,一次重复足以对患有帕金森病的个体进行一致和可靠的移动性评估.
- 这一发现简化了PD患者的关键移动性测试的管理.
- 该研究支持使用单次重复措施来有效和可靠地评估PD的功能性移动性.
相关概念视频
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Parkinson's Disease: Treatment
954
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
954


